Cytokine | Expression in BAL | Reference | Measure | Sensitivity PPV | Specificity NPV |
---|---|---|---|---|---|
IFN- γ | ↑ | [55] | mRNA; during early ACR only |  |  |
↑ | mRNA | 77.7% 73.6% | 85.7% 88.2% | ||
↑ | [71] | Total RNA |  |  | |
0 | [41] | mRNA | Â | Â | |
 | - | [72] | mRNA |  |  |
TNF- α | ↑ | mRNA (experimental) |  |  | |
↑0 | [31] | Protein |  |  | |
0 | [41] | mRNA | Â | Â | |
↓ | [96] | mRNA expressed by AM |  |  | |
↑ | [43] | mRNA expressed by AM |  |  | |
0 | [97] | mRNA expressed by mononuclear cells | Â | Â | |
TGF-β | - | [71] | mRNA |  |  |
 | ↓…↑ |  | mRNA expressed by AM; dramatic increase 15 days after onset of ACR |  |  |
IL-1 | ↑ | [31] | Protein |  |  |
↑ | [32] | mRNA expressed by AM |  |  | |
IL-2 | 0 | mRNA | 44.4% 40.0% | 63.6% 67.7% | |
- | [32] | mRNA expressed by AM | Â | Â | |
IL-4 | ↑ | [16] | mRNA |  |  |
↑ | [35] | mRNA expressed by CD8+ T cells |  |  | |
0 | [34] | mRNA expressed by T cells | Â | Â | |
- | [32] | mRNA expressed by AM | Â | Â | |
IL-5 | 0 | [98] | Protein | Â | Â |
IL-6 | ↑ | mRNA (experimental) |  |  | |
↑ | [16] | mRNA |  |  | |
↑ | [40] | Protein |  |  | |
↑0 | [31] | Protein |  |  | |
0 | [41] | mRNA | Â | Â | |
0 | [42] | Protein | Â | Â | |
↑ | [32] | mRNA expressed by AM |  |  | |
↑0 | mRNA expressed by AM |  |  | ||
IL-8 | ↑0 | Protein |  |  | |
0 | [51] | Protein and mRNA | Â | Â | |
 | 0 | [42] | Protein |  |  |
IL-10 | ↑ | [31] | Protein |  |  |
0 | mRNA | 88.8% 41.0% | 32.3% 84.6% | ||
IL-15 | ↑ | mRNA expressed by AM |  |  | |
↑ | [62] | Blocked IL-2 receptor |  |  | |
0 | [41] | mRNA | Â | Â | |
IL-16 | (↓) | [100] | Protein |  |  |
(↑) | [41] | mRNA |  |  | |
IL-17 | ↑ | Protein |  |  | |
↑ | [51] | mRNA |  |  | |
0 | [41] | mRNA | Â | Â | |
IL-18 | 0 | [101] | Protein | Â | Â |
CXCL10 | ↑ | mRNA |  |  | |
 | ↑ | [80] | Protein |  |  |